Cargando…

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells

INTRODUCTION: Several cytotoxic anticancer drugs inhibit DNA replication and/or mitosis, while EGFR tyrosine kinase inhibitors inactivate EGFR signalling in cancer cell. Both types of anticancer drugs improve the overall survival of the patients with non-small-cell lung cancer (NSCLC), although tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okita, Riki, Wolf, Diana, Yasuda, Koichiro, Maeda, Ai, Yukawa, Takuro, Saisho, Shinsuke, Shimizu, Katsuhiko, Yamaguchi, Yoshiyuki, Oka, Mikio, Nakayama, Eiichi, Lundqvist, Andreas, Kiessling, Rolf, Seliger, Barbara, Nakata, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595469/ https://www.ncbi.nlm.nih.gov/pubmed/26439264 http://dx.doi.org/10.1371/journal.pone.0139809

Ejemplares similares

Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report
por: Maeda, Ai, et al.
Publicado: (2016)

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
por: OKITA, RIKI, et al.
Publicado: (2015)

Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
por: Okita, Riki, et al.
Publicado: (2021)

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
por: MAEDA, AI, et al.
Publicado: (2012)

Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2014)

A case report of intrapulmonary schwannoma
por: Yukawa, Takuro, et al.
Publicado: (2013)

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
por: Okita, Riki, et al.
Publicado: (2019)

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2019)

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients
por: Shimizu, Katsuhiko, et al.
Publicado: (2012)

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
por: Shimizu, Katsuhiko, et al.
Publicado: (2016)

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2017)

Chloroquine Enhances Gefitinib Cytotoxicity in Gefitinib-Resistant Nonsmall Cell Lung Cancer Cells
por: Tang, Mei-Chuan, et al.
Publicado: (2015)

Opposing consequences of signaling through EGF family members: Escape from CTLs could be a bait for NK cells
por: Kiessling, Rolf, et al.
Publicado: (2012)

The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting
por: Fujisaka, Yasuhito, et al.
Publicado: (2023)

Synergistic cytotoxicity of gemcitabine, clofarabine and edelfosine in lymphoma cell lines
por: Valdez, B C, et al.
Publicado: (2014)

Vδ2 T-Cells Kill ZIKV-Infected Cells by NKG2D-Mediated Cytotoxicity
por: Cimini, Eleonora, et al.
Publicado: (2019)

NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
por: Wen, Ti, et al.
Publicado: (2022)

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines
por: Dratkiewicz, Ewelina, et al.
Publicado: (2018)

Cytotoxicity of gemcitabine-loaded thermosensitive liposomes in pancreatic cancer cell lines
por: Affram, Kevin, et al.
Publicado: (2015)

Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD
por: Roos-Engstrand, Ester, et al.
Publicado: (2010)

TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
por: Lu, Hailing, et al.
Publicado: (2013)

Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
por: Wang, Zhan, et al.
Publicado: (2018)

Cytotoxic effects of Gemcitabine-loaded liposomes in human anaplastic thyroid carcinoma cells
por: Celano, Marilena, et al.
Publicado: (2004)

Fabrication and Cytotoxicity of Gemcitabine-Functionalized Magnetite Nanoparticles
por: Popescu, Roxana Cristina, et al.
Publicado: (2017)

Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality
por: Khaleafi, Raghad, et al.
Publicado: (2023)

CYTOTOXIC POTENTIAL OF MOUSE SPLEEN CELLS ON H-2 ANTIBODY-TREATED TARGET CELLS
por: Kiessling, Rolf, et al.
Publicado: (1973)

Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
por: Boerman, Gerharda H., et al.
Publicado: (2015)

Inosine pranobex enhances human NK cell cytotoxicity by inducing metabolic activation and NKG2D ligand expression
por: McCarthy, Michael T., et al.
Publicado: (2019)

NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis
por: Sacramento, Laís A., et al.
Publicado: (2023)

In vitro culture with gemcitabine augments death receptor and NKG2D ligand expression on tumour cells
por: Gravett, Andrew M., et al.
Publicado: (2019)

Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer
por: Shindo, Yoshitaro, et al.
Publicado: (2014)

Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity
por: Yang, Fengqiang, et al.
Publicado: (2013)

CD4(+)CD25(+)Foxp3(+) regulatory T cells suppress NKG2D-mediated NK cell cytotoxicity in peripheral blood
por: Geng, Xu, et al.
Publicado: (2019)

Fluid shear stress enhances natural killer cell's cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing
por: Hu, Bing, et al.
Publicado: (2023)

Altered Expression of Natural Cytotoxicity Receptors and NKG2D on Peripheral Blood NK Cell Subsets in Breast Cancer Patients()
por: Nieto-Velázquez, Nayeli Goreti, et al.
Publicado: (2016)

Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer
por: Shen, Jiaying, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_92ojeicdikh93f0odfd0mb93rr